Monday to Friday | 11 am to 8 pm Saturday & Sun | 11 am to 6 pm Closed on public holidays With the surging popularity of GLP-1 medications such as Semaglutide aka Ozempic for weight loss, comes an epidemic of individuals experiencing accelerated facial ageing from rapid weight loss
Who It May Be Best For Individuals interested in supporting gut microbiome health People focused on metabolic wellness and appetite regulation Adults interested in microbiome-based health strategies Individuals seeking targeted probiotic strains associated with metabolic pathways Suggested Use Follow label directions or guidance from your healthcare professional
Those are the layers that therapy is best positioned to address, no matter what ultimately happens with the medication
Faurholt-Jepsen M, Brage S, Vinberg M, Christensen EM, Knorr U, Jensen HM, et al
GLP-1 receptor agonists were associated with markedly lower risks of major adverse cardiovascular events, progression of kidney disease, venous thromboembolism, and all-cause mortality compared to DPP-4 inhibitor therapy